Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair

Ji Ye Yin, Jie Shen, Zi Zheng Dong, Qiong Huang, Mei Zuo Zhong, De Yun Feng, Hong Hao Zhou, Jian Ting Zhang, Zhao Qian Liu

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Purpose: The purpose of this study is to test the hypothesis that eIF3a may regulate the expression of DNA repair proteins which, in turn, affects response of lung cancer patients to treatments by DNAdamaging anticancer drugs. Experimental Design: Immunohistochemistry was used to determine the expression of eIF3a in 211 human lung cancer tissues followed by association analysis of eIF3a expression with patient's response to platinum-based chemotherapy. Ectopic overexpression and RNA interference knockdown of eIF3a were carried out in NIH3T3 and H1299 cell lines, respectively, to determine the effect of altered eIF3a expression on cellular response to cisplatin, doxorubicine, etoposide (VP-16), vincristine, and vinblastine by using MTT assay. The DNA repair capacity of these cells was evaluated by using host-cell reactivation assay. Real-time reverse transcriptase PCR and Western Blot analyses were carried out to determine the effect of eIF3a on the DNA repair genes by using cells with altered eIF3a expression. Results: eIF3a expression associates with response of lung cancer patients to platinum-based chemotherapy. eIF3a knockdown or overexpression, respectively, increased and decreased the cellular resistance to cisplatin and anthrocycline anticancer drugs, DNA repair activity, and expression of DNA repair proteins. Conclusions: eIF3a plays an important role in regulating the expression of DNA repair proteins which, in turn, contributes to cellular response to DNA-damaging anticancer drugs and patients' response to platinum-based chemotherapy.

Original languageEnglish (US)
Pages (from-to)4600-4609
Number of pages10
JournalClinical Cancer Research
Volume17
Issue number13
DOIs
StatePublished - Jul 1 2011

Fingerprint

Platinum
DNA Repair
Lung Neoplasms
Drug Therapy
Etoposide
Cisplatin
Pharmaceutical Preparations
Proteins
Vinblastine
Vincristine
RNA Interference
Reverse Transcriptase Polymerase Chain Reaction
Real-Time Polymerase Chain Reaction
Research Design
Western Blotting
Immunohistochemistry
Cell Line
DNA
Genes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Yin, J. Y., Shen, J., Dong, Z. Z., Huang, Q., Zhong, M. Z., Feng, D. Y., ... Liu, Z. Q. (2011). Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair. Clinical Cancer Research, 17(13), 4600-4609. https://doi.org/10.1158/1078-0432.CCR-10-2591

Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair. / Yin, Ji Ye; Shen, Jie; Dong, Zi Zheng; Huang, Qiong; Zhong, Mei Zuo; Feng, De Yun; Zhou, Hong Hao; Zhang, Jian Ting; Liu, Zhao Qian.

In: Clinical Cancer Research, Vol. 17, No. 13, 01.07.2011, p. 4600-4609.

Research output: Contribution to journalArticle

Yin, JY, Shen, J, Dong, ZZ, Huang, Q, Zhong, MZ, Feng, DY, Zhou, HH, Zhang, JT & Liu, ZQ 2011, 'Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair', Clinical Cancer Research, vol. 17, no. 13, pp. 4600-4609. https://doi.org/10.1158/1078-0432.CCR-10-2591
Yin, Ji Ye ; Shen, Jie ; Dong, Zi Zheng ; Huang, Qiong ; Zhong, Mei Zuo ; Feng, De Yun ; Zhou, Hong Hao ; Zhang, Jian Ting ; Liu, Zhao Qian. / Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair. In: Clinical Cancer Research. 2011 ; Vol. 17, No. 13. pp. 4600-4609.
@article{f79931a111ab435aab7c3464b096d21c,
title = "Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair",
abstract = "Purpose: The purpose of this study is to test the hypothesis that eIF3a may regulate the expression of DNA repair proteins which, in turn, affects response of lung cancer patients to treatments by DNAdamaging anticancer drugs. Experimental Design: Immunohistochemistry was used to determine the expression of eIF3a in 211 human lung cancer tissues followed by association analysis of eIF3a expression with patient's response to platinum-based chemotherapy. Ectopic overexpression and RNA interference knockdown of eIF3a were carried out in NIH3T3 and H1299 cell lines, respectively, to determine the effect of altered eIF3a expression on cellular response to cisplatin, doxorubicine, etoposide (VP-16), vincristine, and vinblastine by using MTT assay. The DNA repair capacity of these cells was evaluated by using host-cell reactivation assay. Real-time reverse transcriptase PCR and Western Blot analyses were carried out to determine the effect of eIF3a on the DNA repair genes by using cells with altered eIF3a expression. Results: eIF3a expression associates with response of lung cancer patients to platinum-based chemotherapy. eIF3a knockdown or overexpression, respectively, increased and decreased the cellular resistance to cisplatin and anthrocycline anticancer drugs, DNA repair activity, and expression of DNA repair proteins. Conclusions: eIF3a plays an important role in regulating the expression of DNA repair proteins which, in turn, contributes to cellular response to DNA-damaging anticancer drugs and patients' response to platinum-based chemotherapy.",
author = "Yin, {Ji Ye} and Jie Shen and Dong, {Zi Zheng} and Qiong Huang and Zhong, {Mei Zuo} and Feng, {De Yun} and Zhou, {Hong Hao} and Zhang, {Jian Ting} and Liu, {Zhao Qian}",
year = "2011",
month = "7",
day = "1",
doi = "10.1158/1078-0432.CCR-10-2591",
language = "English (US)",
volume = "17",
pages = "4600--4609",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "13",

}

TY - JOUR

T1 - Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair

AU - Yin, Ji Ye

AU - Shen, Jie

AU - Dong, Zi Zheng

AU - Huang, Qiong

AU - Zhong, Mei Zuo

AU - Feng, De Yun

AU - Zhou, Hong Hao

AU - Zhang, Jian Ting

AU - Liu, Zhao Qian

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Purpose: The purpose of this study is to test the hypothesis that eIF3a may regulate the expression of DNA repair proteins which, in turn, affects response of lung cancer patients to treatments by DNAdamaging anticancer drugs. Experimental Design: Immunohistochemistry was used to determine the expression of eIF3a in 211 human lung cancer tissues followed by association analysis of eIF3a expression with patient's response to platinum-based chemotherapy. Ectopic overexpression and RNA interference knockdown of eIF3a were carried out in NIH3T3 and H1299 cell lines, respectively, to determine the effect of altered eIF3a expression on cellular response to cisplatin, doxorubicine, etoposide (VP-16), vincristine, and vinblastine by using MTT assay. The DNA repair capacity of these cells was evaluated by using host-cell reactivation assay. Real-time reverse transcriptase PCR and Western Blot analyses were carried out to determine the effect of eIF3a on the DNA repair genes by using cells with altered eIF3a expression. Results: eIF3a expression associates with response of lung cancer patients to platinum-based chemotherapy. eIF3a knockdown or overexpression, respectively, increased and decreased the cellular resistance to cisplatin and anthrocycline anticancer drugs, DNA repair activity, and expression of DNA repair proteins. Conclusions: eIF3a plays an important role in regulating the expression of DNA repair proteins which, in turn, contributes to cellular response to DNA-damaging anticancer drugs and patients' response to platinum-based chemotherapy.

AB - Purpose: The purpose of this study is to test the hypothesis that eIF3a may regulate the expression of DNA repair proteins which, in turn, affects response of lung cancer patients to treatments by DNAdamaging anticancer drugs. Experimental Design: Immunohistochemistry was used to determine the expression of eIF3a in 211 human lung cancer tissues followed by association analysis of eIF3a expression with patient's response to platinum-based chemotherapy. Ectopic overexpression and RNA interference knockdown of eIF3a were carried out in NIH3T3 and H1299 cell lines, respectively, to determine the effect of altered eIF3a expression on cellular response to cisplatin, doxorubicine, etoposide (VP-16), vincristine, and vinblastine by using MTT assay. The DNA repair capacity of these cells was evaluated by using host-cell reactivation assay. Real-time reverse transcriptase PCR and Western Blot analyses were carried out to determine the effect of eIF3a on the DNA repair genes by using cells with altered eIF3a expression. Results: eIF3a expression associates with response of lung cancer patients to platinum-based chemotherapy. eIF3a knockdown or overexpression, respectively, increased and decreased the cellular resistance to cisplatin and anthrocycline anticancer drugs, DNA repair activity, and expression of DNA repair proteins. Conclusions: eIF3a plays an important role in regulating the expression of DNA repair proteins which, in turn, contributes to cellular response to DNA-damaging anticancer drugs and patients' response to platinum-based chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=79960291133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960291133&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-10-2591

DO - 10.1158/1078-0432.CCR-10-2591

M3 - Article

C2 - 21610145

AN - SCOPUS:79960291133

VL - 17

SP - 4600

EP - 4609

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 13

ER -